IN THE SPOTLIGHT

Targeted Radiation Offers Promise in Patients with Metastasized Small Cell Lung Cancer to the Brain

Targeted Radiation Offers Promise in Patients with Metastasized Small Cell Lung Cancer to the Brain

Targeted Radiation Promising for Brain Metastasis in SCLC

Targeted Radiation Promising for Brain Metastasis in SCLC

Studies Conducted at University of Virginia on Brain Metastasis Recently Reported (Real-world Outcomes of Tarlatamab In Small Cell Lung Cancer, Including Patients With Untreated Brain...

Studies Conducted at University of Virginia on Brain Metastasis Recently Reported (Real-world Outcomes of Tarlatamab In Small Cell Lung Cancer, Including Patients With Untreated Brain...

Tarlatamab Shows Promising Real-World Activity in Extensive-Stage SCLC

Tarlatamab Shows Promising Real-World Activity in Extensive-Stage SCLC

HTMC0435 Plus Chemotherapy Yields Responses in Relapsed ES-SCLC

HTMC0435 Plus Chemotherapy Yields Responses in Relapsed ES-SCLC

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

Shanghai Jiao Tong University School of Medicine Reports Findings in Lung Cancer (Comprehensive analysis of a real-world cohort identifies geranylgeranyl diphosphate synthase 1 as a...

Shanghai Jiao Tong University School of Medicine Reports Findings in Lung Cancer (Comprehensive analysis of a real-world cohort identifies geranylgeranyl diphosphate synthase 1 as a...

U.S. Clinical Trial: PrECOG Listed a New Clinical Trial to Study Platinum/Etoposide Plus Ivonescimab as First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (PrE0510)

U.S. Clinical Trial: PrECOG Listed a New Clinical Trial to Study Platinum/Etoposide Plus Ivonescimab as First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (PrE0510)

Chemoradiotherapy followed by continued immunotherapy for out-of-field progression during consolidation in limited-stage SCLC: a case report

Chemoradiotherapy followed by continued immunotherapy for out-of-field progression during consolidation in limited-stage SCLC: a case report

Kobe University Graduate School of Medicine Reports Findings in Lung Cancer [Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase...

Kobe University Graduate School of Medicine Reports Findings in Lung Cancer [Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase...